TLCS prices IPO/SPO at $19/sh. Of the 50M shares being sold, 58% are in the IPO and 42% are in the SPO: <a href="http://finance.yahoo.com/news/Talecris-Biotherapeutics-bw-1512899435.html?x=0&.v=1" rel="nofollow" target="_blank">http://finance.yahoo.com/news/Talecris-Biotherapeutics-bw-1512899435.html?x=0&.v=1</a> Caveat emptor certainly applies when insiders are unloading $400M worth of their own stock under the cover of an IPO!